NUTX EBITDA Growth
Nutex Health Inc · EBITDA Growth
NUTX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported63.31%period ending
NUTX TTM EBITDA YoY % (58.65% → 63.31%)
Year-over-year change
High-resolution chart · PNG
NUTX ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 63.3138% | |
| 36.3014% | |
| 87.7752% | |
| 4,451.7769% | |
| 5,574.7597% | |
| 4,054.9495% | |
| 1,118.7904% | |
| -46.3151% | |
| 101.0044% | |
| 98.691% | |
| 96.1972% | |
| 103.9985% | |
| -414.2804% | |
| -352.5089% | |
| -394.0739% | |
| -314.5825% | |
| 36.3826% | |
| 167.2651% | |
| 102.0451% | |
| 4,967.9446% | |
| 1,646.1375% | |
| 844.1373% | |
| 921.3681% | |
| -7.0963% | |
| -330.6051% | |
| -2,450.0588% | |
| -1,502.9738% | |
| 20.4384% | |
| 73.7284% | |
| 95.0401% | |
| 91.9303% | |
| -172.2225% | |
| -377.723% | |
| -43,207.7448% | |
| -953.1616% | |
| -190.9551% | |
| 102.6005% | |
| 58.6451% |